Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

NCT05246345 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT05246345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Overall status
Recruiting
Start date
March 7, 2022
Completion date
March 31, 2027
Enrollment
50 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, cll, progressive chronic lymphocytic leukemia, refractory chronic lymphocytic leukemia, relapsed chronic lymphocytic leukemia